Example: Heart Attack

Clinical Trials Sponsored by TaiGen Biotechnology Co., Ltd

Total 18 results

NCT04495322

Recruiting

To Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of TG-1000 in Healthy Volunteers, and the Food Effect on Pharmacokinetics of Single Oral Dose of TG-1000 in Healthy Volunteers.

Conditions: Healthy Chinese Volunteers
NCT03362853

Completed

A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics

Conditions: Healthy Volunteers
NCT01944774

Completed

Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride

Conditions: Pneumonia
NCT02340962

Completed

A Study to Evaluate the Efficacy and Safety of TG-2349 in Combination With Peg-interferon and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1b Infection

Conditions: Hepatitis C, Chronic
NCT02205112

Completed

A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP

Conditions: Community-acquired Pneumonia
NCT01529476

Completed

Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP

Conditions: Pneumonia
NCT02108418

Completed

Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers

Conditions: Healthy
NCT02104427

Completed

PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

Conditions: Multiple Myeloma; Non-Hodgkin Lymphoma; Hodgkin Disease
NCT01537250

Completed

Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)

Conditions: Community-acquired Pneumonia
NCT01529957

Completed

A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion

Conditions: Healthy
NCT01523990

Completed

A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients

Conditions: Healthy; Hepatitis C, Chronic
NCT01458288

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease

Conditions: Multiple Myeloma; Non-hodgkin's Lymphoma; Hodgkin's Disease
NCT01395108

Completed

Clinical Study on Oral Nemonoxacin Malate Capsules

Conditions: Healthy Volunteers
NCT01018979

Completed

Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

Conditions: Multiple Myeloma; Non-Hodgkin Lymphoma; Hodgkin Disease
NCT00822341

Completed

Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of TG-0054 With Single IV Doses Escalation in Healthy Volunteers

Conditions: Healthy
NCT00685698

Completed

Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections

Conditions: Diabetic Foot Infections
NCT00434291

Completed

Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia

Conditions: Community-Acquired Pneumonia
NCT02478125

Terminated

Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer

Conditions: Prostate Cancer